Tandem Diabetes Care Inc (TNDM)
Cash ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 69,234 | 58,868 | 172,517 | 71,181 | 94,613 |
| Short-term investments | US$ in thousands | 369,095 | 409,044 | 444,384 | 552,630 | 390,323 |
| Total current liabilities | US$ in thousands | 247,049 | 195,258 | 165,290 | 131,856 | 103,852 |
| Cash ratio | 1.77 | 2.40 | 3.73 | 4.73 | 4.67 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($69,234K
+ $369,095K)
÷ $247,049K
= 1.77
The cash ratio of Tandem Diabetes Care Inc has shown a gradual decline from 4.67 on December 31, 2020, to 1.77 on December 31, 2024. Despite maintaining a strong cash position initially, the company's ability to cover its short-term liabilities with cash and cash equivalents has weakened over the years. This decreasing trend may indicate potential liquidity challenges or a shift in the company's cash management strategy towards other investments or uses. It is crucial for stakeholders to monitor this trend closely to assess the company's financial health and liquidity position accurately.
Peer comparison
Dec 31, 2024